PT - JOURNAL ARTICLE AU - Wanaratna, Kulthanit AU - Leethong, Pornvimol AU - Inchai, Nitapha AU - Chueawiang, Wararath AU - Sriraksa, Pantitra AU - Tabmee, Anutida AU - Sirinavin, Sayomporn TI - Efficacy and safety of <em>Andrographis paniculata</em> extract in patients with mild COVID-19: A randomized controlled trial AID - 10.1101/2021.07.08.21259912 DP - 2021 Jan 01 TA - medRxiv PG - 2021.07.08.21259912 4099 - http://medrxiv.org/content/early/2021/08/05/2021.07.08.21259912.short 4100 - http://medrxiv.org/content/early/2021/08/05/2021.07.08.21259912.full AB - The authors have withdrawn this manuscript titled "Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial" because this manuscript has been noticed an error of statistical analysis which could be misleading. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialTCTR20210708001Funding StatementThe trial was supported by Thai Traditional Medical Knowledge Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The trial was approved by the Ethics Committee for Research in Human Subjects in the Fields of Thai Traditional and Alternative Medicine, Thailand (No.12-2563).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesManuscript Number: THEIJID-D-21-01999Article Title: Efficacy and safety of Andrographis paniculata extract in patients with mild COVID-19: A randomized controlled trial.International Journal of Infectious Diseases.On Peer review process.